Inventor · disambiguated record
Heping Shi
Also filed as: SHI HEPING
17 granted patents·4 pending applications·27 citations·filing 2013–2024
91Inventor score
Top patents by PatentIndex Score
21 records- 0193US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 0292US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0391US10633411B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 0490US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0587US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 0686US11492368B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2020·Granted Nov 8, 2022·1 cites·15 claims
- 0786US10519188B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·21 claims
- 0886US10508129B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Dec 17, 2019·3 cites·15 claims
- 0984US10336786B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2013·Granted Jul 2, 2019·4 cites·17 claims
- 1084US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1182US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1280US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 1380US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 1477US10696710B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Jun 30, 2020·0 cites·16 claims
- 1576US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1675US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 1772US12311030B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·17 claims
- 1871US11213592B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 4, 2022·0 cites·26 claims
- 1970US2022340613A1Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2060US2017296655A1Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2017·Application pending·0 cites
- 2159US11299512B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Heping Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →